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Abstract: Cytokeratin (pan) and epithelial membrane antigen (EMA) were considered as commonly useful epithelial 
markers to distinguish cancer from lymphoma, but the expression of cytokeratin (pan) and EMA had also been seen 
in some lymphomas. Here, we presented an unusual case of anaplastic large cell lymphoma (ALCL) absence of 
some lymphoid markers (Including CD3, CD20, Pax-5, CD45Ro) and positive for cytokeratin (pan) and EMA, which 
was misdiagnosed as metastatic carcinoma. Our case suggested that the epithelial markers (including cytokeratin 
and EMA) show an overlap with that of ALCL, which represented a diagnostic pitfall for confusing ALCL with meta-
static carcinoma.
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Introduction
Cytokeratins are proteins of keratin-containing 
intermediate filaments which are useful mark-
ers for epithelial cells, Previous studies have 
shown that cytokeratin can also been expressed 
in tumors of non-epithelial origin such as epi-
thelioid sarcoma, epithelioid angiosarcoma [1], 
synovial sarcoma, mesothelioma, chordoma 
and some lymphomas [2]. In this paper, we 
reported a case of cytokeratin-positive ana-
plastic large cell lymphoma in lymph node, 
which was misdiagnosed as a metastatic 
carcinoma.
Case description
A 35-year-old Chinese man presented with 
enlarged right axillary nodes without other sys-
temic symptoms for 3 months. Physical exami-
nation: the enlarged lymph node is about 2cm 
in diameter, with smooth surface, clear bound-
ary and medium texture. The patient had no 
history of malignancy and lack of fever, night 
sweat and rash on body. Serum tumor markers 
including carbohydrate antigen 19-9 (CA19-9), 
carcinoembryonic antigen (CEA) and carbohy-
drate antigen 125 (CA125) were all within the 
normal range. 
Immunohistochemical studies
The biopsy specimen was fixed in 10% buffered 
formalin solution and embedded in paraffin, 
sectioned at 4 µm, and stained with hematoxy-
lin and eosin. Immunohistochemical staining 
was performed by using the streptavidin-perox-
idase system (Ultrasensitive, MaiXin Inc, 
Fuzhou, China) according to the manufacturer’s 
instruction. Heat-induced epitope retrieval was 
performed. The following antibodies (MaiXin 
Inc, China, prediluted) were used: Cytokeratin 
(pan), EMA, CD3, CD20, Pax-5, CD45RO, S-100, 
HMB45, MelanA, Desmin, MyoD1, PLAP, 
CD117, CD15, CD30, ALK/P80 and the Ki-67. 
Positive and negative controls were evaluated 
appropriately for each procedure.
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Pathological findings
The patient was diagnosed as lymphadenopa-
thy and a lymph node biopsy was carried out. 
Hematoxylin and eosin sections showed that 
the normal structure of lymph node was 
destroyed and substituted by atypia tumor cell 
nests (Figure 1A, 1B). In some regions, tumor 
cells grew in sheets (Figure 1C) and infiltrated 
lymph node sinuses (Figure 1D). 
Immunohistochemical stainings showed that 
the tumor cells were positive for cytokeratin 
(pan) (Figure 2A) and EMA, but negative for 
CD3 (Figure 2C), CD20 (Figure 2D), Pax-5 
(Figure 2E), CD45RO, PLAP, CD117, S-100, 
HMB45, MelanA, Desmin and MyoD1. The 
Ki-67 (Figure 2F) labeling index was about 
70%. The tumor cells showed some similar 
characteristics of carcinoma and expression of 
epithelial cells marker. Therefore, the patient 
was diagnosed as metastatic carcinoma and 
then was referred to the department of oncolo-
gy to search for the origin. Because non-malig-
nant tumors were found in other organs by PET-
CT scan, the oncologist advised a revision of 
the pathological diagnosis.
Revision was performed in the Department of 
Pathology in The First Affiliated Hospital of 
China Medical University. The hematoxylin and 
eosin-stained sections showed that the atypi-
cal tumor cells were medium size, with abun-
dant cytoplasm, cell nuclear was enlarged and 
irregular, kidney-shaped or horseshoe-shaped 
nuclei, and prominent smaller eosinophilic 
nucleoli, termed “hallmark cells” (Figure 1C). 
The revision confirmed that the specimen was 
positive for cytokeratin (pan) with a dot-like 
perinuclear positive staining (Figure 2B), the 
infiltrated cells had a strong positive reaction to 
CD30 (Figure 2G) and the anaplastic large cell 
kinase ALK/p80 protein (Figure 2H). CD15 was 
negative. Based on the morphologic and immu-
nophenotypic findings, we concluded that this 
was a ALK-positive systemic anaplastic large 
cell lymphoma. 
Discussion
Recent studies showed that the expression of 
cytokeratin (pan) had also been seen in some 
lymphoma, such as plasmacytoma [3], ALCL, 
diffuse large B-cell lymphoma [4]. Gustmann C 
Figure 1. Hematoxylin and eosin staining. A. The normal structure of lymph node is destroyed and replaced by nests 
of infiltrating tumor cells (hematoxylin-eosin, original magnification ×50). B. The tumor cells presented some similar 
characteristics of carcinoma cells. (hematoxylin-eosin, original magnification ×100). C. The tumor cells showed in a 
patchy distribution and exhibited typical hallmark cells  (hematoxylin-eosin, original magnification ×200). D. Showed 
the tumor cells infiltrates lymph node sinuses. (hematoxylin-eosin, original magnification ×100).
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Figure 2. Immunohistochemical analysis. A. The tumor cells were positive for cytokeratin(pan), roblastic reticulum 
cells showed a typical dendritic shape (Original magnification ×100). B. High magnification showed that positive 
reactivity of cytokeratin(pan) with Golgi-associated dot-like staining pattern. (Original magnification ×200). C. The 
tumor cells were negative for CD3, but T lymphocytes showed a nuclear staining (Original magnification ×100). 
D. CD20, E. Pax-5 were also negative in atypia tumor cells and positive for B lymphocytes. (Original magnification 
×100). F. showed the high Ki-67 labeling index. (Original magnification ×100). G. The large lymphocytes are strongly 
CD30 positive with a membrane and Golgi pattern of staining. (Original magnification ×100). H. ALK/P80 immuno-
histochemistry shows strong cytoplasmic staining in the neoplastic cells. (Original magnification ×100).
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[5] demonstrated that about 27%（5/18）ALCL 
showed positivity for cytokeratin. While both 
ALCL and metastatic carcinoma express EMA, 
therefore, cytokeratin (pan) and EMA immuno-
histochemical studies could not be utilized as 
markers to distinguish ALCL from metastatic 
carcinoma. Our case has identified that ALCL 
exhibits a unique dot-like staining pattern for 
cytokeratin (pan). Whether or not this staining 
pattern may be an useful aspect to definitive 
diagnosis of metastatic carcinoma need more 
case studies to illustrate.
Morphologically, the sinusoidal growth pattern 
is another deceptive feature of ALCL,While this 
is also a typical pattern of metastatic carcino-
ma or melanoma. If the neoplastic cells are 
noncohesive and contain irregular, hyperchro-
matic nuclei with minimal cytoplasm, it sug-
gests the possibility of lymphoma. In this case, 
we need to detect ALK/P80 and CD30 to con-
firm the diagnosis of ALCL.
ALCL was classified as a T cell lymphoma by the 
World Health Organization classification [6]. 
However, 20-30% of ALCL showed antigen dele-
tion of T-cell markers, especially CD3, CD5 and 
CD7, which was reported previously as “null 
cell” (expressing neither B nor T cell specific 
antigens). Recent studies have found that near-
ly all the ALCL could demonstrate T-cell recep-
tor gene rearrangement even if the immunohis-
tochemical analysis of T-cell markers were 
negative [7, 8]. But this rare and diagnostically 
confusing immunophenotype (epithelial mark-
ers positive, B or T cell specific antigens were 
negative) may easily lead to misdiagnosis of the 
tumor as metastatic carcinoma rather than 
lymphoma. Pathologists must be aware of this 
phenomenon to avoid misdiagnosis.
In summary, this case was misdiagnosed with 
metastatic carcinoma because of the similari-
ties in morphology and the positive immunore-
action toward epithelial cells markers and neg-
ative immunoreactivity of lymphocytes. 
However, the presence of hallmark cells and 
CD30, ALK/P80 positivity confirms the diagno-
sis of ALCL. This case emphasizes that cytoker-
atin expression can be a potential pitfall for 
confusing ALCL with metastatic carcinoma. 
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